Background: Molecular profiling is revolutionizing cancer diagnostics and leading to personalized therapeutic approaches. Herein we describe our clinical experience performing targeted sequencing for 31 pediatric neuro-oncology patients. Methods: We sequenced 510 cancer-associated genes from tumor and peripheral blood to identify germline and somatic mutations, structural variants, and copy number changes. Results: Genomic profiling was performed on 31 patients with tumors including 11 high-grade gliomas, 8 medulloblastomas, 6 low-grade gliomas, 1 embryonal tumor with multilayered rosettes, 1 pineoblastoma, 1 uveal ganglioneuroma, 1 choroid plexus carcinoma, 1 chordoma, and 1 high-grade neuroepithelial tumor. In 25 cases (81%), results impacted patient management by: (i) clarifying diagnosis, (ii) identifying pathogenic germline mutations, or (iii) detecting potentially targetable alterations. The pathologic diagnosis was amended after genomic profiling for 6 patients (19%), including a high-grade glioma to pilocytic astrocytoma, medulloblastoma to pineoblastoma, ependymoma to high-grade glioma, and medulloblastoma to CNS high-grade neuroepithelial tumor with BCOR alteration. Multiple patients had pathogenic germline mutations, many of which were previously unsuspected. Potentially targetable alterations were identified in 19 patients (61%). Additionally, novel likely pathogenic alterations were identified in 3 cases: an in-frame RAF1 fusion in a BRAF wild-type pleomorphic xanthoastrocytoma, an inactivating ASXL1 mutation in a histone H3 wild-type diffuse pontine glioma, and an in-frame deletion within exon 2 of MAP2K1 in a low-grade astrocytic neoplasm. Conclusions: Our experience demonstrates the significant impact of molecular profiling on diagnosis and treatment of pediatric brain tumors and confirms its feasibility for use at the time of diagnosis or recurrence.
Background: Molecular profiling is revolutionizing cancer diagnostics and leading to personalized therapeutic approaches. Herein we describe our clinical experience performing targeted sequencing for 31 pediatric neuro-oncology patients. Methods: We sequenced 510 cancer-associated genes from tumor and peripheral blood to identify germline and somatic mutations, structural variants, and copy number changes. Results: Genomic profiling was performed on 31 patients with tumors including 11 high-grade gliomas, 8 medulloblastomas, 6 low-grade gliomas, 1 embryonal tumor with multilayered rosettes, 1 pineoblastoma, 1 uveal ganglioneuroma, 1 choroid plexus carcinoma, 1 chordoma, and 1 high-grade neuroepithelial tumor. In 25 cases (81%), results impacted patient management by: (i) clarifying diagnosis, (ii) identifying pathogenic germline mutations, or (iii) detecting potentially targetable alterations. The pathologic diagnosis was amended after genomic profiling for 6 patients (19%), including a high-grade glioma to pilocytic astrocytoma, medulloblastoma to pineoblastoma, ependymoma to high-grade glioma, and medulloblastoma to CNS high-grade neuroepithelial tumor with BCOR alteration. Multiple patients had pathogenic germline mutations, many of which were previously unsuspected. Potentially targetable alterations were identified in 19 patients (61%). Additionally, novel likely pathogenic alterations were identified in 3 cases: an in-frame RAF1 fusion in a BRAF wild-type pleomorphic xanthoastrocytoma, an inactivating ASXL1 mutation in a histone H3 wild-type diffuse pontine glioma, and an in-frame deletion within exon 2 of MAP2K1 in a low-grade astrocytic neoplasm. Conclusions: Our experience demonstrates the significant impact of molecular profiling on diagnosis and treatment of pediatric brain tumors and confirms its feasibility for use at the time of diagnosis or recurrence.
Authors: Noah A Brown; Larissa V Furtado; Bryan L Betz; Mark J Kiel; Helmut C Weigelin; Megan S Lim; Kojo S J Elenitoba-Johnson Journal: Blood Date: 2014-06-30 Impact factor: 22.113
Authors: Cassie N Kline; Nancy M Joseph; James P Grenert; Jessica van Ziffle; Iwei Yeh; Boris C Bastian; Sabine Mueller; David A Solomon Journal: Neuro Oncol Date: 2016-02-21 Impact factor: 12.300
Authors: Marina N Nikiforova; Abigail I Wald; Melissa A Melan; Somak Roy; Shan Zhong; Ronald L Hamilton; Frank S Lieberman; Jan Drappatz; Nduka M Amankulor; Ian F Pollack; Yuri E Nikiforov; Craig Horbinski Journal: Neuro Oncol Date: 2015-12-17 Impact factor: 12.300
Authors: David T W Jones; Barbara Hutter; Natalie Jäger; Andrey Korshunov; Marcel Kool; Hans-Jörg Warnatz; Thomas Zichner; Sally R Lambert; Marina Ryzhova; Dong Anh Khuong Quang; Adam M Fontebasso; Adrian M Stütz; Sonja Hutter; Marc Zuckermann; Dominik Sturm; Jan Gronych; Bärbel Lasitschka; Sabine Schmidt; Huriye Seker-Cin; Hendrik Witt; Marc Sultan; Meryem Ralser; Paul A Northcott; Volker Hovestadt; Sebastian Bender; Elke Pfaff; Sebastian Stark; Damien Faury; Jeremy Schwartzentruber; Jacek Majewski; Ursula D Weber; Marc Zapatka; Benjamin Raeder; Matthias Schlesner; Catherine L Worth; Cynthia C Bartholomae; Christof von Kalle; Charles D Imbusch; Sylwester Radomski; Chris Lawerenz; Peter van Sluis; Jan Koster; Richard Volckmann; Rogier Versteeg; Hans Lehrach; Camelia Monoranu; Beate Winkler; Andreas Unterberg; Christel Herold-Mende; Till Milde; Andreas E Kulozik; Martin Ebinger; Martin U Schuhmann; Yoon-Jae Cho; Scott L Pomeroy; Andreas von Deimling; Olaf Witt; Michael D Taylor; Stephan Wolf; Matthias A Karajannis; Charles G Eberhart; Wolfram Scheurlen; Martin Hasselblatt; Keith L Ligon; Mark W Kieran; Jan O Korbel; Marie-Laure Yaspo; Benedikt Brors; Jörg Felsberg; Guido Reifenberger; V Peter Collins; Nada Jabado; Roland Eils; Peter Lichter; Stefan M Pfister Journal: Nat Genet Date: 2013-06-30 Impact factor: 38.330
Authors: Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons Journal: Blood Date: 2014-09-08 Impact factor: 22.113
Authors: Ibrahim Qaddoumi; Wilda Orisme; Ji Wen; Teresa Santiago; Kirti Gupta; James D Dalton; Bo Tang; Kelly Haupfear; Chandanamali Punchihewa; John Easton; Heather Mulder; Kristy Boggs; Ying Shao; Michael Rusch; Jared Becksfort; Pankaj Gupta; Shuoguo Wang; Ryan P Lee; Daniel Brat; V Peter Collins; Sonika Dahiya; David George; William Konomos; Kathreena M Kurian; Kathryn McFadden; Luciano Neder Serafini; Hilary Nickols; Arie Perry; Sheila Shurtleff; Amar Gajjar; Fredrick A Boop; Paul D Klimo; Elaine R Mardis; Richard K Wilson; Suzanne J Baker; Jinghui Zhang; Gang Wu; James R Downing; Ruth G Tatevossian; David W Ellison Journal: Acta Neuropathol Date: 2016-01-25 Impact factor: 17.088
Authors: Eric Bouffet; Valérie Larouche; Brittany B Campbell; Daniele Merico; Richard de Borja; Melyssa Aronson; Carol Durno; Joerg Krueger; Vanja Cabric; Vijay Ramaswamy; Nataliya Zhukova; Gary Mason; Roula Farah; Samina Afzal; Michal Yalon; Gideon Rechavi; Vanan Magimairajan; Michael F Walsh; Shlomi Constantini; Rina Dvir; Ronit Elhasid; Alyssa Reddy; Michael Osborn; Michael Sullivan; Jordan Hansford; Andrew Dodgshun; Nancy Klauber-Demore; Lindsay Peterson; Sunil Patel; Scott Lindhorst; Jeffrey Atkinson; Zane Cohen; Rachel Laframboise; Peter Dirks; Michael Taylor; David Malkin; Steffen Albrecht; Roy W R Dudley; Nada Jabado; Cynthia E Hawkins; Adam Shlien; Uri Tabori Journal: J Clin Oncol Date: 2016-03-21 Impact factor: 44.544
Authors: Emily Chan; Andrew W Bollen; Deepika Sirohi; Jessica Van Ziffle; James P Grenert; Cassie N Kline; Tarik Tihan; Arie Perry; Nalin Gupta; David A Solomon Journal: Acta Neuropathol Date: 2017-08-03 Impact factor: 17.088
Authors: Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones Journal: Acta Neuropathol Date: 2019-11-25 Impact factor: 17.088
Authors: Armin R Afshar; Melike Pekmezci; Michele M Bloomer; Nicola J Cadenas; Meredith Stevers; Anuradha Banerjee; Ritu Roy; Adam B Olshen; Jessica Van Ziffle; Courtney Onodera; W Patrick Devine; James P Grenert; Boris C Bastian; David A Solomon; Bertil E Damato Journal: Ophthalmology Date: 2019-12-12 Impact factor: 12.079
Authors: Mazen A Atiq; Jessica L Davis; Jason L Hornick; Brendan C Dickson; Christopher D M Fletcher; Jonathan A Fletcher; Andrew L Folpe; Adrián Mariño-Enríquez Journal: Mod Pathol Date: 2020-07-15 Impact factor: 7.842
Authors: Calixto-Hope G Lucas; Ahmed Gilani; David A Solomon; Xiayuan Liang; Ossama M Maher; Gabriel Chamyan; Bette K Kleinschmidt-Demasters; Arie Perry Journal: Acta Neuropathol Date: 2019-05-22 Impact factor: 17.088
Authors: Melike Pekmezci; Meredith Stevers; Joanna J Phillips; Jessica Van Ziffle; Boris C Bastian; Nadejda M Tsankova; Bette K Kleinschmidt-DeMasters; Marc K Rosenblum; Tarik Tihan; Arie Perry; David A Solomon Journal: Acta Neuropathol Date: 2018-02-10 Impact factor: 17.088